{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:33:44Z","timestamp":1761165224534,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.gassur.2003.11.005","type":"journal-article","created":{"date-parts":[[2004,2,13]],"date-time":"2004-02-13T05:06:52Z","timestamp":1076648812000},"page":"200-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion"],"prefix":"10.1016","volume":"8","author":[{"given":"Elizabeth D.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Beresneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Helsabeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montessa","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Pingpank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.Richard","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gassur.2003.11.005_BIB1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","article-title":"Epidemiology of primary liver cancer","volume":"19","author":"Bosch","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gassur.2003.11.005_BIB2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00000658-200107000-00010","article-title":"Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years","volume":"234","author":"Poon","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2003.11.005_BIB3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01656375","article-title":"The surgical management of primary carcinoma of the liver","volume":"6","author":"Lee","year":"1982","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2003.11.005_BIB4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJM200008103430610","article-title":"Organ donation by unrelated donors","volume":"343","author":"Levinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2003.11.005_BIB5","series-title":"Liver Cancer","first-page":"8","article-title":"Chemotherapy for Hepatocellular Carcinoma","author":"Okada","year":"1997"},{"key":"10.1016\/j.gassur.2003.11.005_BIB6","first-page":"1676","article-title":"Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma","volume":"5","author":"Leung","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gassur.2003.11.005_BIB7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cncr.10236","article-title":"Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy","volume":"94","author":"Leung","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2003.11.005_BIB8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gassur.2003.11.005_BIB9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0168-8278(90)90110-D","article-title":"A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"11","author":"Pelletier","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.gassur.2003.11.005_BIB10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","author":"Groupe d\u2019Etude et de Traitement du Carcinome Hepatocellulaire","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2003.11.005_BIB11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials","volume":"224","author":"Camma","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.gassur.2003.11.005_BIB12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000050696","article-title":"Role of percutaneous ethanol injection in the treatment of hepatocellular carcinoma","volume":"19","author":"Livraghi","year":"2001","journal-title":"Dig Dis"},{"key":"10.1016\/j.gassur.2003.11.005_BIB13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1072-7515(02)01180-8","article-title":"Radiofrequency ablation of unresectable primary liver cancer","volume":"194","author":"Seidenfeld","year":"2002","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.gassur.2003.11.005_BIB14","first-page":"3393","article-title":"Development of a technic for isolated perfusion of the liver","volume":"61","author":"Ausman","year":"1961","journal-title":"N Y State J Med"},{"key":"10.1016\/j.gassur.2003.11.005_BIB15","first-page":"2","article-title":"Isolated hepatic perfusion: A potentially effective treatment for patients with metastatic or primary cancers confined to the liver","volume":"4","author":"Alexander","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.gassur.2003.11.005_BIB16","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.1998.16.4.1479","article-title":"Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver","volume":"16","author":"Alexander","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gassur.2003.11.005_BIB17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0039-6060(98)70200-4","article-title":"First experience and technical aspects of isolated liver perfusion for extensive liver metastasis","volume":"123","author":"Oldhafer","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2003.11.005_BIB18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0960-7404(94)90005-1","article-title":"Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy","volume":"3","author":"Hafstr\u00f6m","year":"1994","journal-title":"Surg Oncol"},{"key":"10.1016\/j.gassur.2003.11.005_BIB19","first-page":"3062","article-title":"A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver","volume":"6","author":"Alexander","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gassur.2003.11.005_BIB20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF00801607","article-title":"Continuous intraoperative external monitoring of perfusate leak using I-131 human serum albumin during isolated perfusion of the liver and limbs","volume":"22","author":"Barker","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.gassur.2003.11.005_BIB21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El-Serag","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2003.11.005_BIB22","series-title":"Cancer: Principles and Practice of Oncology","first-page":"1","article-title":"Regional treatment strategies for unresectable primary or metastatic cancer confined to the liver","author":"Alexander","year":"1996"},{"key":"10.1016\/j.gassur.2003.11.005_BIB23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1634\/theoncologist.5-5-416","article-title":"Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver","volume":"5","author":"Alexander","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.gassur.2003.11.005_BIB24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1067\/msy.2001.110365","article-title":"Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer","volume":"129","author":"Bartlett","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2003.11.005_BIB25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1072-7515(00)00733-X","article-title":"Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies","volume":"191","author":"Libutti","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.gassur.2003.11.005_BIB26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00130404-200203000-00012","article-title":"Isolation perfusion of the liver","volume":"8","author":"Carroll","year":"2002","journal-title":"Cancer J"},{"key":"10.1016\/j.gassur.2003.11.005_BIB27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/sonc.2002.31681","article-title":"Transarterial perfusion of liver metastases","volume":"29","author":"Weinreich","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.gassur.2003.11.005_BIB28","first-page":"301","article-title":"Continuous leaking monitoring during hyperthermic isolated regional perfusion of the lower limb: Techniques and results","volume":"4","author":"Hoekstra","year":"1992","journal-title":"Reg Cancer Treat"},{"key":"10.1016\/j.gassur.2003.11.005_BIB29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/bjs.1800800918","article-title":"Systemic leakage during isolated limb perfusion for melanoma","volume":"80","author":"Klaase","year":"1993","journal-title":"Br J Surg"},{"key":"10.1016\/j.gassur.2003.11.005_BIB30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jso.2930510313","article-title":"Synergistic effects of intratumor administration of cis-diamminedichloroplatinum(II) combined with local hyperthermia in melanoma bearing mice","volume":"51","author":"Kitamura","year":"1992","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.gassur.2003.11.005_BIB31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/02656739409009335","article-title":"Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential","volume":"10","author":"Miller","year":"1994","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.gassur.2003.11.005_BIB32","first-page":"5271","article-title":"Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy","volume":"52","author":"Klostergaard","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.gassur.2003.11.005_BIB33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199612000-00011","article-title":"Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas","volume":"224","author":"Eggermont","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2003.11.005_BIB34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02316812","article-title":"Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor","volume":"4","author":"Olieman","year":"1997","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X03002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X03002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:21:55Z","timestamp":1761074515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X03002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1091255X03002579"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2003.11.005","relation":{},"ISSN":["1091-255X"],"issn-type":[{"type":"print","value":"1091-255X"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2003.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}